- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04840563
Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 Lenses
3. august 2026 opdateret af: Bausch & Lomb Incorporated
Evaluation of Surface Refractive Index Shift and Lens Absorption / Adsorption of Tear Components of Commercially Available Kalifilcon A Lenses Compared to Dailies Total1 and Precision1
This was a single-site, bilateral, repeated-measures insertion study in habitual soft contact lens wearers.
Ten participants were enrolled.
All participants attended a Screening/Dispensing Visit at which informed consent was obtained and eligibility was assessed.
Eligible participants then wore each of three commercially available daily disposable soft contact lens types - kalifilcon A (Bausch + Lomb), Dailies Total1 (delefilcon A, Alcon) and Precision1 (verofilcon A, Alcon), all -3.00 D - bilaterally for wear times of 0.5, 1, 3, 5 and 10 minutes over a total of 6 study visits.
A new lens pair was inserted for each wear time, with a 3-5 minute washout period between lens pairs.
Immediately following removal, the right-eye lens was measured for surface refractive index on a Metricon M-2010 Prism Coupler.
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
Rationale: earlier work (ROC2-20-012) showed a change in surface refractive index for Dailies Total1 (delefilcon A) and Precision1 (verofilcon A) lenses after 5 minutes of wear, attributed to a change in surface water content.
ROC2-21-007 was designed to determine whether that change occurs in less than 5 minutes.
Three study lenses (one test, two controls) were each worn bilaterally.
Wear times of 0.5, 1 and 3 minutes were completed at one visit and 5 and 10 minutes at another visit for each lens type, giving 6 visits of approximately 30 minutes each, each on a separate day; the clinical investigation took approximately 2 weeks.
Lens type order followed the study randomization schedule prepared before enrolment by an unmasked statistician not otherwise involved in the study; unmasked study personnel dispensed and collected study materials so that the participant and Investigator remained masked.
Endpoint: surface refractive index of the worn right-eye lens, measured on a Metricon M-2010 Prism Coupler, compared with unworn (baseline) values for the same lens types.
Continuous data were summarized with n, mean, standard deviation, median, minimum and maximum, and paired t-tests were used to compare unworn with worn values, with p < 0.05 considered statistically significant.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
10
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
New York
-
Rochester, New York, Forenede Stater, 14609
- Bausch & Lomb Incorporated
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Be 18 years or older and have full legal capacity to volunteer.
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Have no active ocular disease or allergic conjunctivitis.
- Not be using any topical ocular medications.
- Be willing and able to follow instructions.
- Have signed a statement of informed consent.
Exclusion Criteria:
- Participating in a conflicting study in the opinion of the Investigator.
- Considered by the Investigator to not be a suitable candidate for participation.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: All Participants: kalifilcon A, Then Dailies Total1, Then Precision1
Each participant wore all three study lens types bilaterally, one lens type per pair of visits, in the order specified by the study randomization schedule (kalifilcon A, then Dailies Total1, then Precision1).
For each lens type a new lens pair was inserted for each wear time of 0.5, 1, 3, 5 and 10 minutes, with a 3-5 minute washout period between lens pairs.
Wear times of 0.5, 1 and 3 minutes were completed at one visit and 5 and 10 minutes at another visit, for a total of 6 visits.
Immediately after removal the right-eye lens was measured for surface refractive index on a Metricon M-2010 Prism Coupler.
|
Commercially available Infuse (kalifilcon A) daily disposable spherical soft contact lens, -3.00 D, worn bilaterally for 0.5, 1, 3, 5 and 10 minutes.
Andre navne:
Commercially available Dailies Total1 (delefilcon A) daily disposable spherical soft contact lens (Alcon), -3.00 D, worn bilaterally for 0.5, 1, 3, 5 and 10 minutes.
Commercially available Precision1 (verofilcon A) daily disposable spherical soft contact lens (Alcon), -3.00 D, worn bilaterally for 0.5, 1, 3, 5 and 10 minutes.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Surface Refractive Index of Worn Lenses
Tidsramme: Unworn lens (baseline) and immediately after 0.5, 1, 3, 5, and 10 minutes of lens wear
|
Immediately following lens removal, the right-eye worn lens for each participant was measured for surface refractive index on a Metricon M-2010 Prism Coupler.
A new lens pair was worn for each wear time.
Surface refractive index is a dimensionless ratio and has no units.
|
Unworn lens (baseline) and immediately after 0.5, 1, 3, 5, and 10 minutes of lens wear
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Jeffery Schafer, OD, MS, Bausch & Lomb Incorporated
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
7. april 2021
Primær færdiggørelse (Faktiske)
15. april 2021
Studieafslutning (Faktiske)
15. april 2021
Datoer for studieregistrering
Først indsendt
7. april 2021
Først indsendt, der opfyldte QC-kriterier
8. april 2021
Først opslået (Faktiske)
12. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
5. august 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
3. august 2026
Sidst verificeret
1. august 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- ROC2-21-007
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant data will not be shared.
This was an internal Bausch + Lomb device performance study; source data are retained in the Trial Master File.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .